HIVE Blockchain Technologies Ltd
NASDAQ:HIVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HIVE Blockchain Technologies Ltd
NASDAQ:HIVE
|
CA |
|
GuocoLand Ltd
SGX:F17
|
SG |
|
F
|
Flexopack SA
ATHEX:FLEXO
|
GR |
|
Ascelia Pharma AB
STO:ACE
|
SE |
|
SS Lazio SpA
F:LZO1
|
IT |
|
Amdocs Ltd
NASDAQ:DOX
|
US |
|
U
|
Uzin Utz SE
SWB:UZU
|
DE |
|
BRP Group Inc
NASDAQ:BWIN
|
US |
|
F
|
Feytech Holdings Bhd
KLSE:FEYTECH
|
MY |
Wall Street
Price Targets
HIVE Price Targets Summary
HIVE Blockchain Technologies Ltd
According to Wall Street analysts, the average 1-year price target for
HIVE
is 4.76 USD
with a low forecast of 3.33 USD and a high forecast of 6.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HIVE's stock price target?
Price Target
4.76
USD
According to Wall Street analysts, the average 1-year price target for
HIVE
is 4.76 USD
with a low forecast of 3.33 USD and a high forecast of 6.15 USD.
What is HIVE Blockchain Technologies Ltd's Revenue forecast?
Projected CAGR
74%
The
compound annual growth rate
of HIVE Blockchain Technologies Ltd's revenue for the next 3 years is
74%.
